, especially when it compared to the Q4–2018. This is because the gross margin in Q4–2018 was a relatively low. In addition, it had recorded the allowance for doubtful accounts for long outstanding receivables
% Gross Profit (After deduct Costs of foods and beverages) 457.6 64.4% 460.6 63.6% Gross Profit (After deduct Cost of Sales and Service) 170.5 24.0% 166.5 23.0% Remark: (1) Percentage of Revenue from main
% (commissioning process) and will commercially run in 2nd quarter of 2019, which is expected to improve the Company's gross profit margin ability and reduce Biodiesel’s production costs. In addition, with the
cost of sales increased by 1.74 million baht, representing a gross margin for the three months 31.79% (2018: ratio 42.76 %). Cost decrease as a result of decreased raw material use 3.00 million baht. the
which decreased from that of the same quarter last year totaling 53.88 million Baht or 19.51% due to a decrease in sales. This resulted in gross profit of 16.09%, increasing by 2.43% from 13.66% in the
expenses on 1st quarter of 2019 increased significantly 74.91 percent from the same period of last year. 1.3 Profit Consolidated (Thousands Baht) 1st Quarter Change 2019 2018 Amount % Gross profit 102,295
long-term employee benefits from enactment of a new labor law, company’s core net profit still came at Baht 7.4 million) which can be summarized as follows: - Gross Profit including Other Income down
%, primary by higher Gross Profit of High-Valued Document. Excluding extra expenses that are combined as part of the cost of sales in 2Q19. Consisting of the impact of the legal adjustment of compensation for
and cost of services Baht 1,266 million) Consolidated gross loss amounting to Baht 75 million or gross loss margin 1% which same rate as last year. The Company posted gross loss Baht 193 million or
% Cost of hospital operations before adj. 294.32 274.71 7% 579.74 532.07 9% Adj. staff benefit 8.15 - 8.15 - Gross margin 120.29 108.76 11% 280.74 234.33 20% % Gross margin 28% 28% 0% 32% 31% 2% % Gross